Androgen receptor antagonist BAY 1161116
Term · Oncology and biomedicine · MLC-T-ONC-010064
An orally bioavailable antagonist of the androgen receptor (AR), with potential antineoplastic activity. Upon oral administration, AR antagonist BAY 1161116 specifically binds to AR, inhibits AR activation, and prevents AR-mediated signaling. This inhibits cell growth in AR-overexpressing tumor cells. AR is overexpressed in prostate cancers and is involved in proliferation, survival and chemoresistance of tumor cells.
| Identifier | MLC-T-ONC-010064 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | AR antagonist BAY 1161116 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-010064",
"term": "Androgen receptor antagonist BAY 1161116",
"field": "Oncology and biomedicine",
"definition": "An orally bioavailable antagonist of the androgen receptor (AR), with potential antineoplastic activity. Upon oral administration, AR antagonist BAY 1161116 specifically binds to AR, inhibits AR activation, and prevents AR-mediated signaling. This inhibits cell growth in AR-overexpressing tumor cells. AR is overexpressed in prostate cancers and is involved in proliferation, survival and chemoresistance of tumor cells.",
"synonyms": [
"AR antagonist BAY 1161116"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/androgen-receptor-antagonist-bay-1161116/"
}
Record 1,072 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.